[ad_1]
The most widely used vaccine in Israel is only moderately less effective against the South African strain, say researchers at Ben-Gurion University.
By Abigail Klein Leichman
(April 4, 2021 / Israel21c) Israeli researchers report that the Pfizer / BioNTech COVID-19 vaccine is as effective against the B.1.1.7 variant of the virus, aka the British variant, as it is against the original strain SARS-CoV-2. The vaccine was shown to be moderately less effective against the B.1.351 (South African) variant and the combined British-South African variants of the coronavirus.
Support
Jewish News Union
With ever-widening geographic, political and social divides, high-quality reports and informed analysis are more important than ever to keeping people connected.
Our ability to cover the most important issues in Israel and the Jewish world – without standard media bias – depends on the support of engaged readers.
If you appreciate the value of our news service and recognize how JNS stands out from the competition, please click on the link and make a one-time or monthly contribution.
We appreciate your support.
[ad_2]
Source link
